Streetbeat News

Stock Prices

VRTX

Vertex Pharmaceuticals Inc.'s stock price is currently at $361.86, marking a 0.81% decrease in the current market session. However, the stock has seen a 3.53% increase over the past month and a 16.54% increase over the past year. The company's P/E ratio of 28.19 is lower than the Biotechnology industry average of 37.07, which could indicate that the stock is undervalued or that shareholders do not expect future growth.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 8:45 pm

F

TSLA

Tesla Inc's (NASDAQ:TSLA) Q3 financial results fell below analysts' estimates, leading to a drop in share prices. Despite potential future catalysts, Gene Munster, co-founder and Managing Partner at Deepwater Asset Manager, predicts a challenging year ahead for Tesla due to prolonged margin pressure and a dampened demand outlook. The company's gross margins were significantly lower than expected, and the potential for margin improvement over the next year was dismissed. However, Tesla's Cybertruck, set to begin deliveries in November, and the company's advantage in building an electric-focused car company from the ground up, are seen as positive factors.

Portfolio Pulse from Chris Katje

October 20, 2023 | 8:36 pm

SLNO

Soleno Therapeutics Inc has filed a prospectus related to the resale of up to 3 million shares of common stock by selling stockholders, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:36 pm

ACRX

AcelRx Pharmaceuticals has received a notice from Nasdaq stating that it is not in compliance with the minimum bid price requirement. The company is evaluating options to regain compliance.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:35 pm

PXD

Pioneer Natural Resources (NYSE:PXD) has outperformed the market over the past 20 years by 4.86% on an annualized basis, producing an average annual return of 12.05%. If an investor had bought $100 of PXD stock 20 years ago, it would be worth $989.86 today.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 8:30 pm

FTII

Futuretech II Acquisition Corp (FTII) has received a written notice from Nasdaq stating that the company is not in compliance with the minimum total holders rule, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:30 pm

SHW

Sherwin-Williams Inc. (NYSE:SHW) shares are currently trading at $237.70, after a 0.50% decrease. Despite a 6.66% fall over the past month, the stock has increased by 11.84% over the past year. The company's price-to-earnings ratio is lower than the aggregate P/E of the Chemicals industry, which could indicate that the stock is undervalued or that shareholders do not expect it to perform better in the future.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 8:30 pm

AMZN

NFLX

Netflix Inc (NASDAQ:NFLX) has seen significant growth since its IPO in 2002, with a $1,000 investment then being worth $377,908.86 today. The company's Q3 report showed revenue and earnings per share surpassing analyst predictions, driving the share price upwards. Netflix ended Q3 with 247.15 million paid global subscribers, adding 8.8 million in the quarter. The company remains a market leader in the streaming sector and continues to gain subscribers.

Portfolio Pulse from Chris Katje

October 20, 2023 | 8:29 pm

F

GM

STLA

The UAW President has stated that there is more to be won from automakers, indicating that the extremely profitable companies have more to give. He noted serious movement at Stellantis and GM.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:26 pm

GROW

U.S. Global Investors has received a notice from Nasdaq regarding the late filing of its Form 10-K. The company is expected to submit the form soon to avoid any potential penalties.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:20 pm